Knowledge of how cells acquire and display MHC/peptide complexes is basic to understanding of how normal and abnormal (eg autoimmune) responses work. One broad goal of the work described in this application is to identify MHC-encoded proteins that are needed for production and presentation of the complexes and to learn about the function of each protein. Mutant human B cell lines in which the formation of MHC/peptide complexes is defective will be isolated and then cloned genes will be transferred into the mutants in order to identify genes that repair the defects. Genes that encode components of a (peptide?) transporter protein and of proteosomes, as well as a gene that is needed for acquisition of class II/peptide complexes, will be emphasized. Various assays will be performed in order to identify the step in antigen processing/presentation that is defective in each kind of mutant. Mutants in which peptide complex formation is impaired produce unstable """"""""empty"""""""" class I or class II molecules that lack bound self-peptides. Stabilization of empty MHC molecules by binding of peptide will be exploited as an assay to systematically screen for peptides that can bind to specific MHC molecules. Mutant cells that bind exogenous peptides acquire high densities of specific MHC/peptide complexes. Such cells will be used as antigen-presenting cells in attempts to stimulate the in vitro outgrowth of complex-specific T cells from non-immune individuals. The goal of the peptide-binding and T cell outgrowth experiments is to expedite ways of using peptides to elicit or suppress specific immune responses, as desired.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI015486-16
Application #
2060223
Study Section
Experimental Immunology Study Section (EI)
Project Start
1978-12-01
Project End
1997-11-30
Budget Start
1993-12-01
Budget End
1994-11-30
Support Year
16
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Genetics
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Kim, S K; DeMars, R (2001) Epitope clusters in the major outer membrane protein of Chlamydia trachomatis. Curr Opin Immunol 13:429-36
Ortiz, L; Angevine, M; Kim, S K et al. (2000) T-cell epitopes in variable segments of Chlamydia trachomatis major outer membrane protein elicit serovar-specific immune responses in infected humans. Infect Immun 68:1719-23
Kim, S K; Angevine, M; Demick, K et al. (1999) Induction of HLA class I-restricted CD8+ CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections. J Immunol 162:6855-66
Ortiz, L; Demick, K P; Petersen, J W et al. (1996) Chlamydia trachomatis major outer membrane protein (MOMP) epitopes that activate HLA class II-restricted T cells from infected humans. J Immunol 157:4554-67
Ceman, S; Rudersdorf, R A; Petersen, J M et al. (1995) DMA and DMB are the only genes in the class II region of the human MHC needed for class II-associated antigen processing. J Immunol 154:2545-56
Ceman, S; Petersen, J W; Pinet, V et al. (1994) Gene required for normal MHC class II expression and function is localized to approximately 45 kb of DNA in the class II region of the MHC. J Immunol 152:2865-73
Celis, E; Tsai, V; Crimi, C et al. (1994) Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci U S A 91:2105-9
Malnati, M S; Ceman, S; Weston, M et al. (1993) Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC. J Immunol 151:6751-6
Sette, A; Ceman, S; Kubo, R T et al. (1992) Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 258:1801-4
Sanchez Perez, M; Diez Orejas, R; Petersen, J W et al. (1990) Differences in specificity of ""DPw2-specific"" cytotoxic T cell clones revealed with HLA-mutant lines: evidence that non-DP HLA genes influence recognition by some clones. Eur J Immunol 20:673-81

Showing the most recent 10 out of 28 publications